State Health Facts April 21, 2022 Interactive Create a custom report compiling data across health topics for a single state or multiple states. See a sample report on reported legal abortions by states and age group
Section 1115 Waiver Watch: Medicaid Pre-Release Services for People Who Are Incarcerated August 19, 2024 Issue Brief In April 2023, the Centers for Medicare and Medicaid Services (CMS) released guidance encouraging states to apply for a new Section 1115 demonstration opportunity to test transition-related strategies to support community reentry for people who are incarcerated. As of August 19, 2024, CMS has approved Section 1115 reentry waiver requests from 11 states, while 13 additional reentry waivers remain pending.
FAQs on Medicare Financing and Trust Fund Solvency May 29, 2024 Issue Brief In discussions of Medicare’s financial condition, attention frequently centers on one specific measure—the solvency of the Medicare Hospital Insurance (HI) trust fund, out of which Medicare Part A benefits are paid. Based on current projections from the Medicare Board of Trustees, the HI trust fund is projected to be depleted in 2036, 12 years from now. These FAQs answer key questions about Medicare financing and trust fund solvency.
The First-Ever Government Negotiation Process for Drugs Has Finished, But the Politics Are Ongoing August 19, 2024 Perspective This post for Health Affairs Forefront examines how the results of the first-ever Medicare drug price negotiations will generate savings for the government and for Medicare beneficiaries, and how candidates’ views on the issue could play a role in the upcoming elections and in the future of government negotiation.
FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program August 20, 2024 Issue Brief The Centers for Medicare & Medicaid Services (CMS) recently concluded the first round of negotiation for the new Medicare Drug Price Negotiation Program, which was established by the Inflation Reduction Act. These FAQs address several questions related to Medicare’s drug price negotiation program and CMS’s implementation of the new program, with a focus on the details that apply for 2026, the first year that negotiated prices will be available under this new program.
Medicare September 20, 2019 Topic Landing Page Explore KFF’s policy research, polling and news on the Medicaid program including eligibility, enrollment and spending; access to care; and Medicaid’s coverage of long-term services and supports.
Election 2024 April 5, 2024 Topic Landing Page This topic page houses KFF resources that are relevant to policy debates in the 2024 elections, including those about abortion, the Affordable Care Act, and Medicare.
Unraveling the Mysteries of Biden vs. Trump on Health Care June 24, 2024 From Drew Altman In his latest column, KFF President and CEO Drew Altman unravels the differences between Trump and Biden on Medicare, abortion, drug costs and other health-related issues that KFF’s new side-by-side candidate analysis examines. From the bird’s eye view, these differences amount to a fork in the road in direction on the role of the federal government in health and federal health spending.
The Collision of Medicaid World Views August 12, 2024 From Drew Altman In his latest column, KFF President and CEO Drew Altman writes about the fundamentally different world views of the Medicaid program by Republicans and Democrats and how those ideological divides have affected policy proposals, sometimes despite the program’s popularity and broad reach.
Is Medicaid Too Big to… Block Grant? March 26, 2024 From Drew Altman In his latest column, KFF President and CEO Drew Altman examines how the politics around the Medicaid program have changed as it has grown much larger and more popular, making it even tougher to block grant the program to cut federal Medicaid spending and hand it off to the states.